How to run survival-endpoint phase II trials with 25% to 40% fewer patients.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2595178815
